These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 8899198)

  • 1. Successful allogeneic bone marrow transplantation in severe chronic mucocutaneous candidiasis syndrome.
    Hoh MC; Lin HP; Chan LL; Lam SK
    Bone Marrow Transplant; 1996 Oct; 18(4):797-800. PubMed ID: 8899198
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Severe aplastic anemia associated with chronic mucocutaneous candidiasis. Immunologic and hematologic reconstitution after allogeneic bone marrow transplantation.
    Deeg HJ; Lum LG; Sanders J; Levy GJ; Sullivan KM; Beatty P; Thomas ED; Storb R
    Transplantation; 1986 May; 41(5):583-6. PubMed ID: 3518164
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Failure of allogeneic bone marrow transplantation to correct Diamond-Blackfan anaemia despite haemopoietic stem cell engraftment.
    Wynn RF; Grainger JD; Carr TF; Eden OB; Stevens RF; Will AM
    Bone Marrow Transplant; 1999 Oct; 24(7):803-5. PubMed ID: 10516686
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Rapid onset of hemolytic anemia after allogeneic bone marrow transplantation from an unrelated ABO major mismatched donor].
    Watanabe H; Asai O; Tada N; Yano S; Katoh A; Katori M; Kobayashi T; Kuraishi Y; Hoshi Y; Itoh K; Aizawa S
    Rinsho Ketsueki; 1997 Jan; 38(1):14-20. PubMed ID: 9028156
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD6+ T cell depleted allogeneic bone marrow transplantation from genotypically HLA nonidentical related donors.
    Soiffer RJ; Mauch P; Fairclough D; Alyea E; Anderson K; Fisher D; Freedman A; Bartlett-Pandite L; Robertson M; Schlossman R; Gollob J; Marcus K; Murray C; Kuhlman C; Freeman A; Nadler L; Ritz J
    Biol Blood Marrow Transplant; 1997 Apr; 3(1):11-7. PubMed ID: 9209736
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Successful allogeneic bone marrow transplantation in a case with myelodysplastic syndrome which developed following Fanconi anemia.
    Ikushima S; Hibi S; Todo S; Sawada T; Matsumoto Y; Iwami H; Tsunamoto K; Kasubuchi Y; Yabe M; Kato S
    Bone Marrow Transplant; 1995 Oct; 16(4):621-4. PubMed ID: 8528182
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Favorable current prognosis after HLA-identical bone marrow transplantation for children with required severe aplastic anemia; evaluation of 30 years of bone marrow transplantation at the Leiden University Medical Center].
    van Steekelenburg M; van Weel-Sipman MH; Zwinderman AH; Hoogerbrugge PM; Vossen JM; Egeler RM
    Ned Tijdschr Geneeskd; 2002 Aug; 146(33):1542-6. PubMed ID: 12212502
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intermediate-dose busulfan and cyclophosphamide as a conditioning regimen for bone marrow transplantation in a case of Fanconi anemia in myelodysplastic transformation.
    Maschan AA; Kryzanovskii OI; Yourlova MI; Skorobogatova EV; Pashanov ED; Potapova YE; Timonova LA; Bogatcheva NY; Samochatova EV; Roumjantzev AG
    Bone Marrow Transplant; 1997 Feb; 19(4):385-7. PubMed ID: 9051250
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bone marrow transplantation in thalassemia major patients using "short" anti-thymocyte globulin therapy in Shiraz, Southern Iran.
    Zakerinia M; Khojasteh HN; Ramzi M; Haghshenas M
    Transplant Proc; 2005 Dec; 37(10):4477-81. PubMed ID: 16387149
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Excellent long-term survival after allogeneic marrow transplantation in patients with severe aplastic anemia.
    Reiter E; Keil F; Brugger S; Kalhs P; Rabitsch W; Hinterberger W; Fischer G; Rosenmayr A; Haas O; Volc B; Lechner K; Greinix HT
    Bone Marrow Transplant; 1997 Jun; 19(12):1191-6. PubMed ID: 9208112
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tacrolimus (FK506) in allogeneic bone marrow transplantation for severe aplastic anemia following orthotopic liver transplantation.
    Trede NS; Warwick AB; Rosoff PM; Rohrer R; Bierer BE; Guinan E
    Bone Marrow Transplant; 1997 Aug; 20(3):257-60. PubMed ID: 9257897
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bone marrow transplantation from matched related donors for patients with Fanconi anemia using low-dose busulfan and cyclophosphamide as conditioning.
    Torjemane L; Ladeb S; Ben Othman T; Abdelkefi A; Lakhal A; Ben Abdeladhim A
    Pediatr Blood Cancer; 2006 Apr; 46(4):496-500. PubMed ID: 16333862
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Allogeneic stem cell transplant from HLA-identical sibling for chronic granulomatous disease and review of the literature.
    Del Giudice I; Iori AP; Mengarelli A; Testi AM; Romano A; Cerretti R; Macrì F; Iacobini M; Arcese W
    Ann Hematol; 2003 Mar; 82(3):189-92. PubMed ID: 12634956
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Allogeneic blood stem cell transplantation in chronic myeloid leukaemia-chronic phase following conditioning with busulphan and cyclophosphamide: a follow up report.
    Saikia TK; Parikh PM; Tawde S; Amare-Kadam PS; Rajadhyaksha S; Chhaya S
    Natl Med J India; 2004; 17(2):71-3. PubMed ID: 15141598
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Successful bone marrow transplantation in a child with red blood cell pyruvate kinase deficiency.
    Tanphaichitr VS; Suvatte V; Issaragrisil S; Mahasandana C; Veerakul G; Chongkolwatana V; Waiyawuth W; Ideguchi H
    Bone Marrow Transplant; 2000 Sep; 26(6):689-90. PubMed ID: 11041572
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Successful unrelated bone marrow transplantation for Shwachman-Diamond syndrome.
    Cesaro S; Guariso G; Calore E; Gazzola MV; Destro R; Varotto S; Zanesco L; Messina C
    Bone Marrow Transplant; 2001 Jan; 27(1):97-9. PubMed ID: 11244445
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fatal immune-mediated pancytopenia and a TRALI-like syndrome associated with high titers of recipient-type antibodies against donor-derived peripheral blood cells after allogeneic bone marrow transplantation following dose reduced conditioning.
    Knop S; Bux J; Kroeber SM; Bader P; Hebart H; Kanz L; Einsele H
    Haematologica; 2004 May; 89(5):ECR12. PubMed ID: 15136241
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ABO blood group barrier in allogeneic bone marrow transplantation revisited.
    Seebach JD; Stussi G; Passweg JR; Loberiza FR; Gajewski JL; Keating A; Goerner M; Rowlings PA; Tiberghien P; Elfenbein GJ; Gale RP; van Rood JJ; Reddy V; Gluckman E; Bolwell BJ; Klumpp TR; Horowitz MM; Ringdén O; Barrett AJ;
    Biol Blood Marrow Transplant; 2005 Dec; 11(12):1006-13. PubMed ID: 16338623
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Successful treatment of refractory acquired pure red cell aplasia (PRCA) by allogeneic bone marrow transplantation.
    Müller BU; Tichelli A; Passweg JR; Nissen C; Wodnar-Filipowicz A; Gratwohl A
    Bone Marrow Transplant; 1999 Jun; 23(11):1205-7. PubMed ID: 10382963
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of Ph1-positive chronic myelogenous leukemia in children: comparison between allogeneic bone marrow transplantation and conventional chemotherapy. Spanish Working Party for BMT in Children (GETMON).
    Muñoz A; Bureo E; Ortega JJ; Richard C; Olivé T; Maldonado MS; Madero L; Díaz MA
    Haematologica; 1998 Nov; 83(11):981-4. PubMed ID: 9864916
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.